Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. Boston Children's Hospital is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Fecal microbiota transplant appears in 1 tracked Healthcare story from August 24, 2026.
Last mentioned: 5h ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Boston Children's Hospital is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Fecal microbiota transplant appears in 1 tracked Healthcare story from August 24, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 9 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Fecal microbiota transplant. Shared-story counts are live from our verified record — not editorial picks.
Boston Children's Hospital researchers found some peanut-allergic patients retained tolerance months after a fecal transplant, suggesting an eventual shift from indefinite immunotherapy to disease modification. The study could reduce chronic management burden and severe reactions for the 33 million Americans with severe food allergies.
Fecal microbiota transplant is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
